Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
NATF Official Statement and Action Plan on Follow-On Biosimiliars: Update and Open Discussion
Saturday, July 11, 2009
12:00-5:00 PM, Boston Massachusetts
This is an important meeting to discuss 3 bills introduced to the US Congress and Senate related to Follow-on Biologics. The agenda includes:
-
Update on Heparin Contaminants and Quality Issues Surrounding Unfractionated Heparin
-
Current Issues and Statements Surrounding Biosimilars and Follow-on Biologics
-
Summary of United States Legislation and Proposed Bills
-
Waxman Bill: H.R. 1427
-
Eschoo Bill: H.R. 1548
-
Schumer Bill: S. 726
-
NATF Official Statement on Follow-On Biosimilars
-
NATF Action Plan
-
Responses from patients, the general public, the International Society on Thrombosis and Haemostatis, public policy makers, and economic experts
More information related to the issue of Biosimilars and Follow-on Biolgoics can be found on NATF's website at natfonline.org/fob_update.php.
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|